Aims/hypothesis Bisphenol-A (BPA) is a widespread endocrine-disrupting chemical that has been associated with type 2 diabetes development. Low doses of BPA modify pancreatic beta cell function and induce insulin resistance; some of these effects are mediated via activation of oestrogen receptors α (ERα) and β (ERβ). Here we investigated whether low doses of BPA regulate the expression and function of ion channel subunits involved in beta cell function. Methods Microarray gene profiling of isolated islets from vehicle-and BPA-treated (100 μg/kg per day for 4 days) mice was performed using Affymetrix GeneChip Mouse Genome 430.2 Array. Expression level analysis was performed using the normalisation method based on the processing algorithm 'robust multi-array average'. Whole islets or dispersed islets from C57BL/ 6J or oestrogen receptor β (ERβ) knockout (Erβ −/− ) mice were treated with vehicle or BPA (1 nmol/l) for 48 h. Whole-cell patchclamp recordings were used to measure Na + and K + currents. mRNA expression was evaluated by quantitative real-time PCR. Results Microarray analysis showed that BPA modulated the expression of 1440 probe sets (1192 upregulated and 248 downregulated genes). Of these, more than 50 genes, including Scn9a, Kcnb2, Kcnma1 and Kcnip1, encoded important Na + and K + channel subunits. These findings were confirmed by quantitative RT-PCR in islets from C57BL/6J BPA-treated mice or whole islets treated ex vivo. Electrophysiological measurements showed a decrease in both Na + and K + currents in BPA-treated islets. The pharmacological profile indicated that BPA reduced currents mediated by voltage-activated K + channels (K v 2.1/2.2 channels) and large-conductance Ca 2+ -activated K + channels (K Ca 1.1 channels), which agrees with BPA's effects on gene expression. Beta cells from ERβ −/− mice did not present BPA-induced changes, suggesting that ERβ mediates BPA's effects in pancreatic islets. Finally, BPA increased burst duration, reduced the amplitude of the action potential and enlarged the action potential halfwidth, leading to alteration in beta cell electrical activity.
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Introduction
Pancreatic beta cells play a major role in glucose homeostasis because they biosynthesise and release insulin, a key hormone in blood glucose regulation. Decreased insulin release in response to glucose results in chronic hyperglycaemia, a hallmark of type 2 diabetes, a metabolic disease that affects over 400 million people around the world [1] . Glucose-stimulated insulin secretion (GSIS) from pancreatic beta cells is controlled by electrical activity. In the absence of stimulatory glucose concentrations, beta cells maintain a hyperpolarised membrane potential due to the high activity of the ATP-sensitive K + channel (K ATP channel). Upon glucose stimulation, K ATP channel activity decreases due to the rise in the ATP : ADP ratio. This reduction in activity increases membrane input resistance and, consequently, small depolarising currents produce important changes in the membrane potential, generating an oscillatory (bursting) electrical activity that alternates between a hyperpolarised silent phase and a depolarised phase with action potentials [2] [3] [4] . This bursting pattern of electrical activity induces an oscillatory pattern of intracellular Ca 2+ concentration [5] and exocytosis of insulin-containing vesicles [6] . In mouse beta cells, the depolarisation phase of the action potential depends on the activation of voltage-activated Ca 2+ channels, while the repolarisation phase depends on currents generated by delayed rectifying voltage-activated K + channels (K v channels) K v 2.1/ 2.2 [7] [8] [9] and large-conductance Ca 2+ -activated K + channels (K Ca 1.1 channels) [10] . Mouse beta cells express the voltageactivated Na + channels (Na v channels) Na v 1.3 and Na v 1.7. Na v 1.3 participates in the depolarisation of the action potential and affects insulin secretion [11] ; Na v 1.7 does not participate in insulin release, yet it might play a role in insulin production [12] and beta cell survival [13] . The repolarisation phase between bursts of action potential is due to small-conductance Ca 2+ -activated K + channels (K Ca 2.3 channels) [6, 14, 15] . Type 2 diabetes results from gene-environment interactions over time. Genetic alterations in the expression of voltage-activated channels have important consequences for beta cell function and the development of type 2 diabetes [6, 14] . Additionally, animal studies have shown that exposure to bisphenol-A (BPA) alters beta cell function and induces insulin resistance [16] [17] [18] [19] . BPA is found in the urine of 93% of USA citizens [20] and its concentrations in human serum varies between 1 and 25 nmol/l, depending on sex, age and geographical regions, among other factors [21] . BPA has been added by the European Chemical Agency (ECHA) to the candidate list of substances of very high concern due to its endocrine-disrupting properties [22] . In beta cells, low concentrations of BPA (e.g. 1 nmol/l, in vitro) trigger extranuclearinitiated actions via oestrogen receptors α (ERα) and β (ERβ). Within a few minutes, BPA blocks K ATP channels via ERβ and potentiates GSIS [19] . Longer in vitro BPA treatments (up to 48 h) upregulate insulin mRNA expression and increase insulin content as well as GSIS in an ERα-dependent manner [17] . Recent work demonstrated that BPA treatment for 48 h downregulated the voltage-activated Ca 2+ channel Ca v 2.3 in an ERβ-dependent manner, leading to decreased amplitude of action potential and diminished exocytosis in the absence of stimulatory glucose levels. Surprisingly, GSIS was still enhanced by BPA treatment [23] .
Here, we investigated whether BPA modulated the expression and activity of ion channel subunits in pancreatic islets. This study may help us to understand the regulation of GSIS by this common endocrine-disrupting chemical (EDC).
Methods
Chemical substances and animals The chemical substances used herein are described in the electronic supplementary material (ESM) Methods. Adult male mice, OF1 (11 weeks old; Charles River, Barcelona, Spain) for in vivo treatment (shown in Fig. 1 ) and C57BL/6J (10-14 weeks old; Envigo, Barcelona, Spain) for the rest of the experiments, were kept under standard housing conditions (12 h light-dark cycle, food ad libitum) in polypropylene veterinary cages. Mice with knockout of the Erβ gene (also known as Esr2) (Erβ −/− mice), supplied by Jan-Åke Gustafsson's laboratory, were generated as previously described [24] . BPA treatment For in vivo experiments (three to seven mice per condition), BPA was dissolved in tocopherol-stripped corn oil; a total of 100 μg/kg per day (two injections of 50 μg/kg per day) was administered subcutaneously for 4 days. The same volume of tocopherol-stripped corn oil (100 μl) was used as vehicle. Sixteen hours after the last injection, mice were killed and islets were isolated. For ex vivo experiments, BPA was prepared each week by dissolution in DMSO (used as vehicle).
Culture of islets and dispersed islet cells Pancreatic islets were isolated using collagenase (Sigma, St Louis, MO, USA) as described [25] . For some experiments, pancreatic islets were dispersed into isolated cells [26] . Before any treatment, whole islets and dispersed cells were cultured for 48 h at 37°C in a humidified atmosphere of 95% O 2 and 5% CO 2 . See ESM Methods for further details.
Microarray analysis Islets from three BPA-treated OF1 male mice were isolated. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Venlo, the Netherlands) and 1 μg was used to obtain the gene expression profile of each sample. Biotinylated cRNA (10 μg) prepared from total RNA was hybridised on an Affymetrix GeneChip Mouse Genome 430 2.0 Array (Affymetrix, Santa Clara, CA, USA). Microarrays were scanned using GeneChip Scanner 3000 7G (Affymetrix, Santa Clara, CA, USA) and were processed with GeneChip Operating System (GCOS) 1. . Genes are grouped together and are connected by a series of branches (clustering tree or dendrogram) according to the average linkage method (cluster-to-cluster distance is defined as the average distance between all members of one cluster and all members of another cluster) using the Euclidean distance (distance threshold = 3.26) as a measure of similarity. The rows in the heat map represent cluster genes and their measurements, while columns represent different experimental conditions; the scales were assessed by the unweighted pair group method with arithmetic mean (UPGMA) algorithm, which associates the similarity between the samples (top right scale: 0, 0.45 and 18.9) and the genes (top left scale: 0, 6.28 and 12.57). The coloured support boxes to the right highlight clusters (1 to 7). The scaled expression value, denoted as the row z-score, is plotted in yellow-blue colour scale with blue indicating decreased expression (low), black indicating unchanged expression and yellow indicating increased expression (high). Expression data are shown for genes with log 2 (fold change) differences of expression >0.58 (p<0.05). (b) Expanded view of hierarchical clustering heat maps for pancreatic genes of interest detected within clusters 2 (blue box), 3 (green box) and 7 (black box), showing the expression signatures of gene candidates in PBA-treated mice, as determined by applying k means clustering algorithms (k=10; maximum iterations 50). (c) Scatter plot with log 2 fold change of DEGs between control and BPA-treated islets (p<0.05). Selected upregulated and downregulated genes in islets are highlighted in blue (indicating decreased expression) and in yellow (indicating increased expression) (n=3 mice per group). (d) The predicted Biological Process GO terms identified to be upregulated (n=18 terms) or downregulated (n=10 terms) in BPA-treated islets. The p value was used to determine the significance of enrichment or overrepresentation of terms for each annotation. The ranking score was obtained using enrichment −log 10 (p value) from the predicted target genes. The x-axis represents score and the y-axis represents the top enriched signalling pathways USA). All experiments were performed at 32-34°C. See Ref. [23] and ESM Methods for further details.
Real-time PCR Quantitative RT-PCR (qRT-PCR) was performed using the CFX96 Real-Time System (Bio-Rad Laboratories, Hercules, CA, USA). RNA was extracted using RNeasy Micro kit (Qiagen) and reverse-transcribed using the High-Capacity cDNA Reverse Transcription kit (Applied Biosystems, Foster City, CA, USA). Amplification reactions were performed as described [23] . Values were analysed with CFX Manager Version 1.6 (Bio-Rad) and expressed as the relative expression in respect of control values (2 −ΔΔCt ) [29] . Hprt was used as housekeeping gene. Similar results were obtained when Gapdh was used as housekeeping gene (data not shown). The primers used herein are listed in ESM Table 1 .
Statistical analysis Experimenters were not blind to group assignment and outcome assessment. GraphPad Prism 5.0 software (GraphPad Software, La Jolla, CA, USA) was used for most statistical analyses. Data are expressed as the mean ± SEM. To assess differences between groups, we used two- Relationship between Na + current density (Na + currents in pA normalised to the cell capacitance in pF) and the voltage of the prepulses in dispersed cells from wild-type (WT) (f) and Erβ −/− (g) mice treated ex vivo with vehicle (control, n=9 beta cells) or BPA 1 nmol/l (n=12 beta cells) for 48 h. Data are shown as means ± SEM of the number of cells recorded. These cells were isolated from five (f) or three (g) mice on at least three different days: *p≤0.05, **p≤0.01 vs control at the same V h (Student's t test). V h , holding potential tailed Student's t test or ANOVA when appropriate. For nonparametric data we used Mann-Whitney and Kruskal-Wallis ANOVA tests (followed by Dunn's test), depending on the experimental groups involved in the comparison. Except for the microarray analysis (see above), a p value ≤0.05 was considered statistically significant.
Results

BPA regulates ion channel subunits expression in mouse islets
To study the effects of BPA on beta cell gene expression, we treated adult OF1 male mice with vehicle (control; n = 3) or BPA 100 μg/kg per day (n = 3) for 4 days. Afterwards, we performed a microarray analysis of islets obtained from both groups. Hierarchical clustering analysis of differentially expressed genes showed a clear separation between control and BPA-treated islets (Fig. 1a) . In vivo BPA treatment significantly modified the expression of 1440 probe sets, of which 1192 were upregulated and 248 downregulated. Overall, our analysis identified 50 genes related to ion channel subunits within clusters 2, 3 and 7, including Cacn2d1, Kcnma1 and Scn9a (Fig. 1b,c and Table 1 ). Based on these observations, we performed a DAVID analysis to identify potentially enriched biological processes among the putative target genes of the differentially expressed genes (DEGs) using GO terms (http://www.geneontology.org), and to identify the related pathways using the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway database (https://www.genome. jp/kegg; Release 89.0, January 1, 2019). Gene ontology enrichment analysis revealed several DEGs related to ion channel subunit regulation (Fig. 1c) . Besides, based on these DEGs, 18 upregulated and ten downregulated signalling pathways were identified in BPA-treated islets predicted to be mainly related to ion channels (Fig. 1d) .
BPA reduces the expression of Na + channel subunits and Na + currents via ERβ The Na v 1.7 channel is the most abundant Na + channel in mouse beta cells, contributing to approximately 85% of the Na + current [30] . Our microarray analysis indicated that expression of the Na v 1.7 channel, encoded by Scn9a, was downregulated upon BPA exposure (Fig. 1, Table 1 ). To confirm these data, we measured Scn9a expression in islets from C57BL/6J BPA-treated mice (100 μg/kg per day for 4 days) or mouse islets treated ex vivo (BPA 1 nmol/l for 48 h). We observed that BPA treatment diminished Scn9a expression in mouse islets in vivo and ex vivo (Fig. 2a,b) . To assess whether this downregulation affected Na + currents in beta cells, we recorded the currents using perforated patchclamp whole-cell recordings in response to a depolarising pulse from −70 mV to 10 mV, preceded by a prepulse from −150 mV to 0 mV to remove inactivation of Na v 1.7 channel currents [11] (ESM Fig. 1 ). As expected, BPA treatment significantly reduced voltage-activated Na + currents, possibly due to Scn9a downregulation. Of note, expression of Scn3a, which encodes the Na v 1.3 channel, was not modified by BPA treatment ( Table 1) . As a positive control of the oestrogenic effects of BPA, we measured Na + currents in control and 17β-oestradiol-treated beta cells. The 17β-oestradiol-treated beta cells presented reduced voltage-activated Na + currents when compared with control beta cells (ESM Fig. 2a,b) .
Our recent findings suggest that, in pancreatic islets, BPA 1 nmol/l downregulates the voltage-activated Ca 2+ channel Ca v 2.3 and decreases the R-type Ca 2+ current in an ERβ-dependent manner [23] . To evaluate whether ERβ played a role in the regulation of Na + currents upon BPA exposure, we treated islets from wild-type and Erβ −/− mice with BPA 1 nmol/l for 48 h. While BPA decreased Scn9a expression (Fig. 2c) and Na + currents (Fig. 2e,f) in wild-type mouse islets, its effects on Scn9a expression (Fig. 2d) and Na + currents (Fig. 2g) were abolished in islets from Erβ −/− mice.
Moreover, treatment with the ERβ agonist diarylpropionitrile (DPN, 1 nmol/l) decreased Na + currents (ESM Fig. 2c ), which supports a role for ERβ in the modulation of Na + currents.
BPA modulates the expression of different K + channel subunits As demonstrated by our microarray analysis, BPA modulated the expression of several genes related to K + channels (see Table 1 ). To confirm these changes, we measured Kcnab2, Kcnc4 and Kcnj12 mRNA expression in islets from BPA-treated mice (100 μg/kg per day for 4 days) or mouse islets treated ex vivo (BPA 1 nmol/l for 48 h) (ESM Fig. 3 ). As observed in the microarray analysis, Kcnab2 and Kcnc4 expression was increased (ESM Fig. 2a,b,d,e) , while Kcnj12 was downregulated by BPA treatment (ESM Fig. 3c,f) .
BPA reduces the expression of K + channel subunits and K + currents via ERβ The voltage-activated K + channels K v 2.1 (encoded by Kcnb1) and K v 2.2 (Kcnb2), as well as the K Ca 1.1 channel (Kcnma1), are major contributors of the repolarisation phase of the action potential in beta cells [10, 15, 31] . Furthermore, K + channel-interacting protein 1 (encoded by Kcnip) seems to be important for GSIS [32] . We assessed whether BPA treatment modulated the expression of these channel subunits and observed that, except for Kcnb1, mRNA expression of Kcnb2, Kcnma1 and Kcnip1 was decreased by BPA treatment in vivo (Fig. 3a-d ) and ex vivo (Fig. 3e-h ). BPA's effects on Kcnb2, Kcnip1 and Kcnma1 mRNA expression was abrogated in islets from Erβ −/− mice (Fig. 3m-p) when compared with wild-type littermate control mice (Fig. 3i-l) .
To determine whether BPA-induced downregulation of these K + channels would be reflected in the K + efflux, we recorded K + currents in beta cells from wild-type and Erβ −/− mice using the patch-clamp technique in the whole-cell configuration. Figure 4a shows the recordings of the K + currents in response to depolarising voltage pulses from −60 mV to +80 mV from a holding potential of −70 mV in cells from wild-type mice. When compared with vehicle-treated cells, currents were significantly smaller in BPA-treated cells starting from 0 mV, which is about the peak of glucoseinduced action potentials (Fig. 4b) . Measurements of the whole-cell K + currents showed that BPA had no effect on peak current density in beta cells from Erβ −/− mice (Fig. 4c) . We further assessed whether ERβ was indeed involved in the regulation of K + currents by measuring K + currents in control and DPN-treated cells. We observed that DPN treatment decreased K + currents, supporting a role for ERβ in the modulation of K + currents (ESM Fig. 4 ). K + currents result from the passage of K + through several types of voltage-and Ca
2+
-activated K + channels whose expression was changed by BPA exposure (Figs 1 and 3 , ESM Fig. 2 ). To determine which K + -channel subtypes were altered by BPA exposure, we measured K + current in mouse beta cells in the absence or presence of iberiotoxin (IbTx, a specific blocker of K Ca 1.1 channels), or stromatoxin-1 (ScTx1, a selective inhibitor of the homotetrameric K v 2.1 and K v 2.2 channels). In the presence of 100 nmol/l IbTx, the peak current density was decreased by BPA, although to a lesser extent than in the absence of the blocker (Fig. 4d) . Similarly, BPA diminished K + currents even in the presence of ScTx1 100 nmol/l (Fig. 4e) . These results show that BPA reduces both K v 2.1/2.2 and K Ca 1.1 channel subtypes, consistent with the BPA-induced downregulation of Kcnb2 and Kcnma1. To evaluate whether the effects of BPA on K + currents were due to its oestrogenic activity, we measured K + currents in control and 17β-oestradiol-treated cells. Surprisingly, contrary to its effect on Na + currents (ESM Fig. 2a,b) , 17β-oestradiol did not modify K + currents (ESM Fig. 5 ).
BPA alters electrical activity The electrical activity in response to an increase in the external glucose concentration (from 0 mmol/l to 11 mmol/l) was recorded from dissociated beta cells using the perforated patch-clamp technique (see details in ESM Fig. 6 ). Compared with vehicle-treated control beta cells (Fig. 5a) , BPA treatment altered the characteristic single burst of dissociated beta cells (Fig. 5b) . The burst duration, measured as the time of action potential firing (Fig. 5c) or as the percentage of time firing action potentials in the burst (Fig.  5d) , was increased by BPA. As previously shown, a reduction in the amplitude of action potentials was due to decreased Ca 2+ currents after BPA-induced Ca v 2.3 downregulation. Here we show that BPA reduced the amplitude of the action potential after hyperpolarisation (Fig. 5e,f) and enlarged the half-width of the action potential (Fig. 5g) , indicating that BPA induced a reduction in K + currents as reported above. Furthermore, because of the changes in the action potential waveform, the AUC of the action potential also diminished (Fig. 5h) .
Discussion
Pancreatic beta cells encode information with electrical signals. In response to glucose, beta cells produce bursts of action potentials, generated by the activation of ion channels expressed in their membrane, which ultimately stimulate insulin secretion. Thus, any alteration in the expression and/or activation of ion channels in beta cells leads to alteration of insulin secretion and disturbance of glucose homeostasis. Our findings indicate that environmentally relevant doses of BPA alter ion channel expression in beta cells in an ERβ-dependent manner. Consequently, whole-cell Ca 2+ [23] , K + and Na + currents were reduced, altering the shape of action potentials and modifying beta cell electrical activity. Studies in humans and animal models suggest that anomalies in beta cell function, including alterations of beta cell electrical activity, play important roles in the aetiology of type 2 diabetes [33, 34] . Thus, the changes in the expression and activity of ion channels described herein might contribute to the diabetogenic action of BPA observed in animal models [16, 35, 36] and in epidemiological human studies [37] [38] [39] .
Microarray analysis indicated that the expression of more than 50 genes encoding ion channel subunits were either upregulated or downregulated in response to BPA treatment in vivo. It has been shown that the treatment used here induces insulin resistance and hyperinsulinaemia in the non-fasted state [16, 18] . This BPA dose can be considered low as it is only twice the 'reference dose' (50 μg/kg per day) believed by the US Environmental Protection Agency to be safe over a lifetime. An oral dose of BPA equal to this reference dose rapidly altered GSIS, decreasing GSIS second phase in obese individuals (mean BMI 31 kg/m 2 ) [40] . In 2015, the European Union reduced the tolerable BPA daily intake to 4 μg/kg [41] .
The changes in gene expression observed in vivo were reproduced in primary cultured beta cells treated with BPA 1 nmol/l. Of note, this BPA concentration is similar to that found in human serum [20] . The fact that BPA alters ion channel expression in primary cells indicates that BPA acts directly on beta cells and, therefore, the changes observed in vivo are not the result of islet adaptation to counteract insulin resistance. Nonetheless, we cannot completely discount some indirect effects of BPA in our in vivo results.
Voltage-activated K + channels are responsible for the outward currents underlying the falling phase of the action potential [42] . Kcnb2, encoding the K v 2.2 channel, is involved in the mouse beta cell electrical activity and its inhibition impairs GSIS [43] . Here, Kcnb2 expression was decreased by BPA both in vivo and ex vivo. The related channel K v 2.1 (encoded by Kcnb1) is responsible for most of the outward current during action potential repolarisation and its ablation increases insulin release [31, 44] . However, the expression of Kcnb1 did not significantly change upon BPA exposure. BPA treatment also decreased expression of Kcnip1, which encodes the major β-subunit of K v channels expressed in mouse beta cells [32] . Although the role of Kcnip1 is poorly understood, silencing of Kcnip1 potentiates GSIS without altering insulin transcription in MIN6N8 beta cells [32] . Our patch-clamp experiments showed that BPA reduced K + outward currents. To study BPA's effects on K v channels in isolation, we blocked the K Ca 1.1 channel (which would be activated with the voltage-clamp protocol employed) with iberiotoxin. We observed a reduction in BPA-induced voltage-activated K + currents. However, we cannot differentiate between the closely related K v 2.1 and K v 2.2 channels in these experiments. The BPA-induced decrease in K + current could be caused by the diminished expression of K v 2.2 channel subunits, although we cannot rule out a BPA-elicited change in the biophysical properties of some K + channels, particularly the K v 2.1 channel whose gene expression remained unchanged.
In addition to the effect of BPA in voltage-activated K v 2.1/ K v 2.2 channels, we investigated whether BPA affected K Ca 1.1 channels, which are critical in action potential shaping [6] . For this purpose, we employed ScTx1 as a blocker of K v 2.1/K v 2.2 channels. Our results indicate that BPA decreased a fraction of the large outward current that was resistant to ScTx1 and hence carried by K Ca 1.1 channels, indicating that K Ca 1.1 channels are sensitive to BPA. This effect could be attributed to the BPA-induced downregulation of Kcnma1, which encodes the α1 subunit of K Ca 1.1 channels. K Ca 1.1 channels are Ca 2+ -and voltage-dependent channels that, in mouse beta cells, play a part mostly in cells with large Ca 2+ currents, in which K Ca 1.1 channel blockade increased spike amplitude and potentiated GSIS [10] .
Changes in the expression of K v and K Ca 1.1 channel subunits could explain the change in the shape of action potentials and the alteration of the electrical activity pattern induced by BPA exposure. The decreased activity of Ca v 2.3 channels in the presence of 1 nmol/l BPA [23] could be responsible for the diminished amplitude of the action potential. A decrease in Ca 2+ entry would contribute to a diminished activation of K Ca 1.1 channels that, together with downregulation of K Ca 1.1 and K v 2.2 channels, results in wider action potentials. Given the role of K + current in beta cell electrical activity [6] , this effect of BPA exposure should cause longer bursts of electrical activity (present data) and may explain, at least partially, the enhanced GSIS already described in BPA-exposed beta cells [16, 17, 23] .
Mouse beta cells express two main types of Na + channels, Na v 1.3 and Na v 1.7, whose roles are less understood compared (Fig. 5e ), which culminates in increased insulin release. Note that the Na + channels Na v 1.3 and Na v 1.7 are not included because their role in the stimulus-secretion coupling model is still unclear. GK, glucokinase; V m , membrane potential with Ca 2+ and K + channels. The Na v 1.3 channel is responsible for only a small part of the total Na + current and it may play a role in the depolarisation of the action potential [30] . Alternatively, the Na v 1.7 channel, encoded by Scn9a, corresponds to 85% of the Na + current [30] , although its role is yet to be unveiled as the Na v 1.7 channel is inactivated at physiological membrane potentials. While no alterations in GSIS are observed in Scn9a −/− mice, these mice present higher insulin content relative to wild-type counterparts [12] . Furthermore, Na v 1.7 channel inhibition increases both Ins1 and Ins2 mRNA expression [12] . These data suggest that Na v 1.7 channels may be associated with insulin biosynthesis. It has been shown that BPA augments insulin content through an ERα/ERK pathway [17] . However, it remains to be determined whether the BPAinduced Snc9a downregulation observed in the present study is associated with the increase in insulin content observed in BPA-treated beta cells. Of note, our experiments using beta cells from Erβ −/− mice indicated that BPA decreased Scn9a, Kcnb2 and Kcnma1 expression, as well as Na + and K + currents, in an ERβ-dependent manner. The use of a global Erβ knockout may represent a handicap in our study as the ERβ receptor is important for other tissues involved in glucose homeostasis. Hence, it might be suggested that the absence of ERβ could indirectly affect beta cells in vivo. Nevertheless, this in vivo component seems unlikely in our model, at least considering the ion channels studied herein. If we carefully analyse the current-voltage curves for beta cells from wild-type and Erβ −/− mice, we can see that they are identical. Moreover, our data with DPN, an ERβ agonist, fully reproduced BPA's effects on Na + and K + currents, reinforcing the role played by ERβ in the BPAinduced changes identified in beta cells. Of note, our findings do not rule out the involvement of other oestrogen receptors, such as ERα and G protein-coupled oestrogen receptor 1 (GPER), in the pathway activated by BPA. The changes in the expression of ion channel subunits, ion channel-mediated currents and electrical activity presented here suggest that low doses of BPA alter beta cell function via ERβ. These effects of BPA could be responsible, at least in part, for the previously described increase in GSIS in vivo and ex vivo [16, 17, 23] . Moreover, Na v 1.7 channel downregulation opens the possibility of a new regulatory pathway activated by ERβ to regulate insulin biosynthesis. As the BPA concentration used herein was similar to that found in the human population, these results reinforce the likely diabetogenic action of BPA.
Thus, our present results establish a mechanistic link to explain the BPA-induced enhancement in GSIS, placing the main channels involved in beta cell electrical activity as key targets of a diabetogenic EDC (Fig. 6) . Moreover, understanding how BPA regulates the shape of action potentials in beta cells is important for revealing the mechanisms by which this EDC acts in other excitable cells, including neurons and cardiac, skeletal and smooth muscle cells. This may be relevant to explain the actions of BPA on the nervous system and its effects in cardiovascular disease [45] .
